Richard Scott Struthers, President and CEO of Crinetics Pharmaceuticals ($CRNX), made three open market sales of company shares over the past year, totaling about $773 thousand. His latest sale occurred on September 26, 2025. These transactions rank 5,491st among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 trades per seller. Struthers recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 8785 | $37.77 | 1,382,983.0000 | 94,548,000 | 0.63% | 0.01% |
| March 16, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 13196 | $37.11 | 1,391,768.0000 | 94,548,000 | 0.94% | 0.01% |
| Feb. 23, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Common Stock | 62000 | $0.00 | 1,404,964.0000 | 94,548,000 | 4.62% | 0.07% |
| Feb. 23, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 94,548,000 | 9999.99% | 0.24% |
| Dec. 18, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 16342 | $9.28 | 1,314,564.0000 | 94,548,000 | 1.26% | 0.02% |
| Dec. 18, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 16342 | $0.00 | 0.0000 | 94,548,000 | 100.00% | 0.02% |
| Dec. 18, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 28400 | $0.00 | 259,058.0000 | 94,548,000 | 9.88% | 0.03% |
| Dec. 18, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 28400 | $15.29 | 1,342,964.0000 | 94,548,000 | 2.16% | 0.03% |
| Sept. 26, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 4000 | $45.00 | 1,298,222.0000 | 92,926,000 | 0.31% | 0.00% |
| May 14, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 90400 | $0.00 | 1,302,222.0000 | 92,926,000 | 6.49% | 0.10% |
| May 14, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 90400 | $0.00 | 1,302,222.0000 | 92,926,000 | 7.46% | 0.10% |
| April 2, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 81270 | $1.91 | 1,302,222.0000 | 92,926,000 | 6.66% | 0.09% |
| April 2, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 81270 | $0.00 | 0.0000 | 92,926,000 | 100.00% | 0.09% |
| March 19, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 875 | $34.83 | 1,220,952.0000 | 92,926,000 | 0.07% | 0.00% |
| March 19, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 16463 | $34.17 | 1,221,827.0000 | 92,926,000 | 1.33% | 0.02% |
| Feb. 20, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Stock Option (Right to Buy) | 313000 | $0.00 | 313,000.0000 | 92,926,000 | 9999.99% | 0.34% |
| Feb. 20, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Common Stock | 89000 | $0.00 | 1,238,290.0000 | 92,926,000 | 7.74% | 0.10% |
| Dec. 2, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 10000 | $57.57 | 1,149,290.0000 | 68,175,000 | 0.86% | 0.01% |
| May 8, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 107448 | $9.28 | 1,266,738.0000 | 68,175,000 | 9.27% | 0.16% |
| May 8, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 107448 | $49.40 | 1,159,290.0000 | 68,175,000 | 8.48% | 0.16% |
| May 8, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 107448 | $0.00 | 16,342.0000 | 68,175,000 | 86.80% | 0.16% |
| April 18, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 350 | $0.00 | 1,159,290.0000 | 68,175,000 | 0.03% | 0.00% |
| April 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 20000 | $0.00 | 81,270.0000 | 68,175,000 | 19.75% | 0.03% |
| April 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 20000 | $1.91 | 1,159,640.0000 | 68,175,000 | 1.75% | 0.03% |
| April 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 40951 | $9.28 | 1,180,591.0000 | 68,175,000 | 3.59% | 0.06% |
| April 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Non-qualified stock option (Right to Buy) | 40951 | $0.00 | 123,790.0000 | 68,175,000 | 24.86% | 0.06% |
| April 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 40951 | $49.17 | 1,139,640.0000 | 68,175,000 | 3.47% | 0.06% |
| March 18, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | F | Common Stock | 12687 | $38.14 | 1,139,640.0000 | 68,175,000 | 1.10% | 0.02% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Common Stock | 65000 | $0.00 | 1,152,327.0000 | 68,175,000 | 5.98% | 0.10% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 68,175,000 | 9999.99% | 0.35% |
| Feb. 12, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 60000 | $0.00 | 1,087,327.0000 | 68,175,000 | 5.23% | 0.09% |
| Feb. 12, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 20000 | $0.00 | 1,087,327.0000 | 68,175,000 | 1.87% | 0.03% |
| Feb. 12, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 20000 | $0.00 | 1,087,327.0000 | 68,175,000 | 1.87% | 0.03% |
| Feb. 12, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | G | Common Stock | 20000 | $0.00 | 1,087,327.0000 | 68,175,000 | 1.87% | 0.03% |
| Nov. 9, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 50000 | $1.91 | 1,087,327.0000 | 32,344,371,000 | 4.82% | 0.00% |
| Nov. 9, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Incentive stock option (Right to Buy) | 50000 | $0.00 | 101,270.0000 | 32,344,371,000 | 33.05% | 0.00% |
| Nov. 2, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 918 | $9.28 | 1,038,245.0000 | 32,344,371,000 | 0.09% | 0.00% |
| Nov. 2, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 918 | $29.95 | 1,037,327.0000 | 32,344,371,000 | 0.09% | 0.00% |
| Nov. 3, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 199082 | $9.28 | 1,236,409.0000 | 32,344,371,000 | 19.19% | 0.00% |
| Nov. 3, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 199082 | $30.56 | 1,037,327.0000 | 32,344,371,000 | 16.10% | 0.00% |
| Nov. 2, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Non-qualified stock option (Right to Buy) | 918 | $0.00 | 363,823.0000 | 32,344,371,000 | 0.25% | 0.00% |
| Nov. 3, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Non-qualified stock option (Right to Buy) | 199082 | $0.00 | 164,741.0000 | 32,344,371,000 | 54.72% | 0.00% |
| Aug. 14, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Incentve stock option (Right to Buy) | 10000 | $0.00 | 151,270.0000 | 0 | 6.20% | 0.00% |
| Aug. 14, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | M | Common Stock | 10000 | $1.91 | 1,037,327.0000 | 0 | 0.97% | 0.00% |
| July 13, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 14157 | $20.35 | 1,027,327.0000 | 0 | 1.36% | 0.00% |
| July 12, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 11459 | $20.17 | 1,041,484.0000 | 0 | 1.09% | 0.00% |
| July 11, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 24384 | $20.14 | 1,052,943.0000 | 0 | 2.26% | 0.00% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | S | Common Stock | 50000 | $20.81 | 1,077,327.0000 | 0 | 4.44% | 0.00% |
| March 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | F | Common Stock | 4628 | $17.12 | 1,127,327.0000 | 0 | 0.41% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Common Stock (right to buy) | 287700 | $0.00 | 287,700.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Struthers Richard Scott | President & CEO | A | Common Stock | 61650 | $0.00 | 1,131,955.0000 | 0 | 5.76% | 0.00% |